Literature DB >> 31902489

Differential innate immune responses induced by Mycoplasma hyopneumoniae and Mycoplasma hyorhinis in various types of antigen presenting cells.

Bettina S Trueeb1, Roman Othmar Braun2, Gaël Auray3, Peter Kuhnert4, Artur Summerfield5.   

Abstract

Mycoplasma (M.) hyopneumoniae is the etiological agent of enzootic pneumonia in pigs and is closely related to M. hyorhinis, which can be isolated from the healthy mucosal surfaces of the upper respiratory tract. In rare cases it can also cause arthritis and polyserositis. Since the innate immune system is an important first line of defense and promotes adaptive immune responses, we characterized the innate immune response of various antigen presenting cells (APCs) to M. hyopneumoniae and M. hyorhinis, which differ in their pathogenicity in vivo. Porcine peripheral blood mononuclear cells were infected with different multiplicities of infection (MOI) of live and inactivated porcine mycoplasmas. Both Mycoplasma species induced strong tumour necrosis factor (TNF) responses in monocytes, with a stronger activation by M. hyorhinis. This higher stimulatory activity was also confirmed for CD40 upregulation. Conventional and plasmacytoid dendritic cells (cDC and pDC, respectively) did not or poorly respond to mycoplasmas in terms of TNF expression but more efficiently in terms of CD40 upregulation. Again, these responses were generally stronger with M. hyorhinis than with M. hyopneumoniae. Both Mycoplasma species also activated B cells in terms of CD25 upregulation, proliferation, and IgM secretion. Interestingly, while the induction of CD25 and in particular proliferation was higher with M. hyorhinis, the IgM secretion did not differ between the two species with the exception of the highest dose of M. hyopneumoniae,which appeared to suppress IgM responses. Taken together, our results provide a comparative analysis of innate immune response with different porcine APCs and demonstrate Mycoplasma species-dependent differences, which could relate to their different pathogenicity in vivo.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; DC subsets; Innate immune response; M. hyopneumoniae; M. hyorhinis; Monocytes

Mesh:

Substances:

Year:  2019        PMID: 31902489     DOI: 10.1016/j.vetmic.2019.108541

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

1.  Clinical effect of reduning combined with gamma globulin treatment on symptom improvement serum levels of IL-6, 25-(OH)D and LDH in children with severe mycoplasma pneumonia.

Authors:  Xingna Ma; Wei Gao; Jinyu An
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

Review 2.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

Review 3.  Coinfections and their molecular consequences in the porcine respiratory tract.

Authors:  Georges Saade; Céline Deblanc; Juliette Bougon; Corinne Marois-Créhan; Christelle Fablet; Gaël Auray; Catherine Belloc; Mily Leblanc-Maridor; Carl A Gagnon; Jianzhong Zhu; Marcelo Gottschalk; Artur Summerfield; Gaëlle Simon; Nicolas Bertho; François Meurens
Journal:  Vet Res       Date:  2020-06-16       Impact factor: 3.683

4.  Pathogenicity & virulence of Mycoplasma hyopneumoniae.

Authors:  Fernanda M A Leal Zimmer; Jéssica Andrade Paes; Arnaldo Zaha; Henrique Bunselmeyer Ferreira
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

Review 5.  Beware of Mycoplasma Anti-immunoglobulin Strategies.

Authors:  Yonathan Arfi; Carole Lartigue; Pascal Sirand-Pugnet; Alain Blanchard
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.